» Articles » PMID: 23786621

Virulence-related Traits of Epidemic Acinetobacter Baumannii Strains Belonging to the International Clonal Lineages I-III and to the Emerging Genotypes ST25 and ST78

Overview
Journal BMC Infect Dis
Publisher Biomed Central
Date 2013 Jun 22
PMID 23786621
Citations 80
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Acinetobacter baumannii is responsible for large epidemics in hospitals, where it can persist for long time on abiotic surfaces. This study investigated some virulence-related traits of epidemic A. baumannii strains assigned to distinct MLST genotypes, including those corresponding to the international clones I-III as well as emerging genotypes responsible for recent epidemics.

Methods: Genotyping of bacteria was performed by PFGE analysis and MLST according to the Pasteur's scheme. Biofilm formation on polystyrene plates was assessed by crystal violet staining; resistance to desiccation was evaluated on glass cover-slips when kept at room-temperature and 31% relative humidity; adherence to and invasion of A549 human alveolar epithelial cells were determined by the analysis of viable bacteria associated with or internalized by A549 human alveolar epithelial cells; Galleria mellonella killing assays were used to analyze the virulence of A. baumannii in vivo.

Results: The ability to form biofilm was significantly higher for A. baumannnii strains assigned to ST2 (international clone II), ST25 and ST78 compared to other STs. All A. baumannii strains survived on dry surfaces for over 16 days, and strains assigned to ST1 (international clone I) and ST78 survived for up to 89 and 96 days, respectively. Adherence to A549 pneumocytes was higher for strains assigned to ST2, ST25 and ST78 than other genotypes; a positive correlation exists between adherence and biofilm formation. Strains assigned to ST78 also showed significantly higher ability to invade A549 cells. No significant differences in the killing of G. mellonella worms were found among strains.

Conclusions: Elevated resistance to desiccation, high biofilm-forming capacity on abiotic surfaces and adherence to A549 cells might have favoured the spread and persistence in the hospital environment of A. baumannii strains assigned to the international clones I and II and to the emerging genotypes ST25 and ST78.

Citing Articles

Inhibition of biofilm formation and preformed biofilm in by resveratrol, chlorhexidine and benzalkonium: modulation of efflux pump activity.

Migliaccio A, Stabile M, Triassi M, De E, De Gregorio E, Zarrilli R Front Microbiol. 2024; 15:1494772.

PMID: 39736993 PMC: 11684338. DOI: 10.3389/fmicb.2024.1494772.


Dietary zinc deficiency promotes Acinetobacter baumannii lung infection via IL-13 in mice.

Palmer L, Traina K, Juttukonda L, Lonergan Z, Bansah D, Ren X Nat Microbiol. 2024; 9(12):3196-3209.

PMID: 39548344 PMC: 11800279. DOI: 10.1038/s41564-024-01849-w.


H-NS is a Transcriptional Repressor of the CRISPR-Cas System in Acinetobacter baumannii ATCC 19606.

Kim K, Islam M, Bang S, Kim J, Lee C, Lee J J Microbiol. 2024; 62(11):999-1012.

PMID: 39527185 DOI: 10.1007/s12275-024-00182-5.


Bacterial acquisition of host fatty acids has far-reaching implications on virulence.

Waters J, Eijkelkamp B Microbiol Mol Biol Rev. 2024; 88(4):e0012624.

PMID: 39475267 PMC: 11653727. DOI: 10.1128/mmbr.00126-24.


How long do bacteria, fungi, protozoa, and viruses retain their replication capacity on inanimate surfaces? A systematic review examining environmental resilience versus healthcare-associated infection risk by "fomite-borne risk assessment".

Kramer A, Lexow F, Bludau A, Koster A, Misailovski M, Seifert U Clin Microbiol Rev. 2024; 37(4):e0018623.

PMID: 39388143 PMC: 11640306. DOI: 10.1128/cmr.00186-23.


References
1.
Giannouli M, Cuccurullo S, Crivaro V, Di Popolo A, Bernardo M, Tomasone F . Molecular epidemiology of multidrug-resistant Acinetobacter baumannii in a tertiary care hospital in Naples, Italy, shows the emergence of a novel epidemic clone. J Clin Microbiol. 2010; 48(4):1223-30. PMC: 2849555. DOI: 10.1128/JCM.02263-09. View

2.
de Breij A, Eveillard M, Dijkshoorn L, van den Broek P, Nibbering P, Joly-Guillou M . Differences in Acinetobacter baumannii strains and host innate immune response determine morbidity and mortality in experimental pneumonia. PLoS One. 2012; 7(2):e30673. PMC: 3275605. DOI: 10.1371/journal.pone.0030673. View

3.
Peleg A, Seifert H, Paterson D . Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev. 2008; 21(3):538-82. PMC: 2493088. DOI: 10.1128/CMR.00058-07. View

4.
van Dessel H, Dijkshoorn L, van der Reijden T, Bakker N, Paauw A, van den Broek P . Identification of a new geographically widespread multiresistant Acinetobacter baumannii clone from European hospitals. Res Microbiol. 2004; 155(2):105-12. DOI: 10.1016/j.resmic.2003.10.003. View

5.
Cabral M, Soares N, Aranda J, Parreira J, Rumbo C, Poza M . Proteomic and functional analyses reveal a unique lifestyle for Acinetobacter baumannii biofilms and a key role for histidine metabolism. J Proteome Res. 2011; 10(8):3399-417. DOI: 10.1021/pr101299j. View